Screening Tests for Renal Impairment in Patients with Type 2 Diabetes: The what, when, and how

References

• . National Institutes of Health and National Institute of Diabetes and Digestive and Kidney Diseases. USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health; 2009
   Google Scholar
• . Coresh J, Selvin E, Stevens LA, . Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17):2038–2047
   PubMed Web of Science ®Google Scholar
• . Koro CE, Lee BH, Bowlin SJ. Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States. Clin Ther. 2009;31(11):2608–2617
   PubMed Web of Science ®Google Scholar
• . Huang ES, Basu A, O'Grady M, Capretta JC. Projecting the future diabetes population size and related costs for the U.S. Diabetes Care. 2009;32(12):2225–2229
   PubMed Web of Science ®Google Scholar
• . Vassalotti JA, Fox CH, Becker BN. Risk factors and screening for chronic kidney disease. Adv Chronic Kidney Dis. 2010;17(3):237–245
   Google Scholar
• . Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 2003;63(1):225–232
   PubMed Web of Science ®Google Scholar
• . Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy. Diabetes. 1983;32( suppl 2):S64–S78
   PubMed Web of Science ®Google Scholar
• . Collins AJ, Vassalotti JA, Wang C, . Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease. Am J Kidney Dis. 2009;53( suppl 3):S71–S77
   PubMed Web of Science ®Google Scholar
• . Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144(1): 21–28
   PubMed Web of Science ®Google Scholar
• . Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19): 2486–2497
   PubMed Web of Science ®Google Scholar
• . Chen J, Muntner P, Hamm LL, . The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med. 2004;140(3): 167–174
   PubMed Web of Science ®Google Scholar
• . Gall MA, Hougaard P, Borch-Johnsen K, Parving HH. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. BMJ. 1997;314(7083):783–788
   PubMed Web of Science ®Google Scholar
• . KDOQI. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis. 2007;49( suppl 2):S12–S154
   PubMed Web of Science ®Google Scholar
• . Araki S, Haneda M, Sugimoto T, . Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes. Diabetes. 2005;54(10):2983–2987
   Google Scholar
• . Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS. Regression of microalbuminuria in type 1 diabetes. N Engl J Med. 2003;348(23):2285–2293
   PubMed Web of Science ®Google Scholar
• . Wall BM, Hardison RM, Molitch ME, Marroquin OC, McGill JB, August PA. High prevalence and diversity of kidney dysfunction in patients with type 2 diabetes mellitus and coronary artery disease: the BARI 2D baseline data. Am J Med Sci. 2010;339(5):401–410
   Google Scholar
• . Yokoyama H, Oishi M, Kawai K, Sone H. Reduced GFR and microalbuminuria are independently associated with prevalent cardiovascular disease in type 2 diabetes: JDDM study 16. Diabet Med. 2008;25(12):1426–1432
   Google Scholar
• . Gansevoort RT, Nauta FL, Bakker SJ. Albuminuria: all you need to predict outcomes in chronic kidney disease? Curr Opin Nephrol Hypertens. 2010;19(6):513–518
   Google Scholar
• . Gansevoort RT, de Jong PE. The case for using albuminuria in staging chronic kidney disease. J Am Soc Nephrol. 2009;20(3):465–468
   Google Scholar
• . Jerums G, Panagiotopoulos S, Premaratne E, MacIsaac RJ. Integrating albuminuria and GFR in the assessment of diabetic nephropathy. Nat Rev Nephrol. 2009;5(7):397–406
   PubMed Web of Science ®Google Scholar
• . Brocco E, Fioretto P, Mauer M, . Renal structure and function in non-insulin dependent diabetic patients with microalbuminuria. Kidney Int Suppl. 1997;63:S40–S44
   PubMedGoogle Scholar
• . Tuttle KR, Stein JH, DeFronzo RA. The natural history of diabetic nephropathy. Semin Nephrol. 1990;10(3):184–193
   Google Scholar
• . Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med. 1984;310(6):356–360
   PubMed Web of Science ®Google Scholar
• . Molitch ME, DeFronzo RA, Franz MJ, ; American Diabetes Association. Nephropathy in diabetes. Diabetes Care. 2004;27( suppl 1):S79–S83
   PubMed Web of Science ®Google Scholar
• . Bakris GL, Weir MR, Shanifar S, . Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study. Arch Intern Med. 2003;163(13):1555–1565
   PubMed Web of Science ®Google Scholar
• . Duckworth W, Abraira C, Moritz T, ; VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360(2):129–139
   PubMed Web of Science ®Google Scholar
• . Ismail-Beigi F, Craven T, Banerji MA, . Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet. 2010;376(9739):419–430
   PubMed Web of Science ®Google Scholar
• . ADVANCE Collaborative GroupPatel A, MacMahon S, Chalmers J, . Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560–2572
   PubMed Web of Science ®Google Scholar
• . Ruggenenti P, Perna A, Gherardi G, . Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet. 1999;354(9176):359–364
   PubMed Web of Science ®Google Scholar
• . Peterson JC, Adler S, Burkart JM, . Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med. 1995;123(10):754–762
   PubMed Web of Science ®Google Scholar
• . Gall MA, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving HH. Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes. 1995;44(11):1303–1309
   Google Scholar
• . Wachtell K, Ibsen H, Olsen MH, . Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med. 2003;139(11):901–906
   PubMed Web of Science ®Google Scholar
• . Feldt-Rasmussen B. Microalbuminuria and clinical nephropathy in type 1 (insulin-dependent) diabetes mellitus: pathophysiological mechanisms and intervention studies. Dan Med Bull. 1989;36(5):405–415
   Google Scholar
• . Preiss DJ, Godber IM, Gunn IR. How to measure renal function in clinical practice: eating cooked meat alters serum creatinine concentration and eGFR significantly. BMJ. 2006;333(7577):1072
   Google Scholar
• . de Jager DJ, Voormolen N, Krediet RT, Dekker FW, Boeschoten EW, Grootendorst DC; NECOSAD Study Group. Association between time of referral and survival in the first year of dialysis in diabetics and the elderly [published online ahead of print July 16, 2010]. Nephrol Dial Transplant
   Google Scholar
• . American Diabetes Association. Standards of medical care in diabetes–2010. Diabetes Care. 2010;33( suppl 1):S11–S61
   PubMed Web of Science ®Google Scholar
• . Brick N, Ellis P. The significance of the timing of referral for renal care. J Ren Care. 2009;35(1):33–41
   Google Scholar
• . Kinchen KS, Sadler J, Fink N, . The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med. 2002;137(6):479–486
   PubMed Web of Science ®Google Scholar
• . Gillenwater JY, Grayhack JT, Howards SS, Mitchell ME. Adult and Pediatric Urology. 4th ed. Philadelphia, PA: Lippincott, Williams and Wilkins; 2002
   Google Scholar
• . Lamb EJ, MacKenzie F, Stevens PE. How should proteinuria be detected and measured? Ann Clin Biochem. 2009;46(pt 3):205–217
   PubMed Web of Science ®Google Scholar
• . Fine LG, Salehmoghaddam S. Proteinuria. In: Clinical Methods. The History, Physical, and Laboratory Examinations. Stonehame, MA: Butterworth Publishers; 1990. http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=cm&part=A5435. Accessed August 19, 2010
   Google Scholar
• . Lambers Heerspink HJ, Gansevoort RT, Brenner BM, . Comparison of different measures of urinary protein excretion for prediction of renal events. J Am Soc Nephrol. 2010;21(8):1355–1360
   Google Scholar
• . Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41
   PubMed Web of Science ®Google Scholar
• . Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461–470
   PubMed Web of Science ®Google Scholar
• . Poggio ED, Wang X, Greene T, Van Lente F, Hall PM. Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol. 2005;16(2):459–466
   PubMedGoogle Scholar
• . Rigalleau V, Lasseur C, Perlemoine C, . Estimation of glomerular filtration rate in diabetic subjects: Cockcroft formula or modification of Diet in Renal Disease study equation? Diabetes Care. 2005;28(4): 838–843
   Google Scholar
• . Levey AS, Stevens LA, Schmid CH, . A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612
   PubMed Web of Science ®Google Scholar
• . Nguyen MT, Maynard SE, Kimmel PL. Misapplications of commonly used kidney equations: renal physiology in practice. Clin J Am Soc Nephrol. 2009;4(3):528–534
   Google Scholar
• . Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem. 1992;38(10):1933–1953
   PubMed Web of Science ®Google Scholar
• . Accetta NA, Gladstone EH, DiSogra C, Wright EC, Briggs M, Narva AS. Prevalence of estimated GFR reporting among US clinical laboratories. Am J Kidney Dis. 2008;52(4):778–787
   PubMed Web of Science ®Google Scholar
• . Shlipak MG, Sarnak MJ, Katz R, . Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005;352(20):2049–2060
   PubMed Web of Science ®Google Scholar
• . Herget-Rosenthal S, Trabold S, Pietruck F, Holtmann M, Philipp T, Kribben A. Cystatin C: efficacy as screening test for reduced glomerular filtration rate. Am J Nephrol. 2000;20(2):97–102
   PubMed Web of Science ®Google Scholar
• . Tidman M, Sjöström P, Jones I. A Comparison of GFR estimating formulae based upon s-cystatin C and s-creatinine and a combination of the two. Nephrol Dial Transplant. 2008;23(1):154–160
   PubMed Web of Science ®Google Scholar
• . Zahran A, El-Husseini A, Shoker A. Can cystatin C replace creatinine to estimate glomerular filtration rate? A literature review. Am J Nephrol. 2007;27(2):197–205
   Google Scholar
• . Herget-Rosenthal S, Bokenkamp A, Hofmann W. How to estimate GFR-serum creatinine, serum cystatin C or equations? Clin Biochem. 2007;40(3–4):153–161
   PubMed Web of Science ®Google Scholar
• . Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med. 2001;134(8):629–636
   PubMed Web of Science ®Google Scholar